Novel Targets and Biomarkers for Anti-atherosclerotic Therapy

被引：0
|
作者：
Bobryshev, Yuri V. [1 ,2 ]
机构：
[1] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia
[2] St Vincents Hosp, Sydney, NSW 2052, Australia
来源：
CURRENT PHARMACEUTICAL DESIGN | 2013年 / 19卷 / 33期
关键词：
atherosclerosis; atherogenesis; targets; biomarkers; anti-atherosclerotic therapy; T cells; macrophages; dendritic cells; immune-inflammatory cells; ATHEROSCLEROSIS; LDL;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：5837 / 5839
页数：3
相关论文
共 50 条
  • [1] Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy
    Reiner, Zeljko
    [J]. KOREAN CIRCULATION JOURNAL, 2018, 48 (12) : 1097 - 1119
  • [2] Using microgravity for defining novel anti-atherosclerotic therapy
    Verhaar, A
    Krishnadath, KK
    Peppelenbosch, MP
    [J]. CURRENT GENOMICS, 2005, 6 (06) : 487 - 490
  • [3] NOVEL ANTI-ATHEROSCLEROTIC MRNA-BASED THERAPY
    Totary-Jain, H.
    Hetherington, I.
    Wickramage, I.
    Hortu, I.
    Vanwye, J.
    [J]. ATHEROSCLEROSIS, 2022, 355 : E26 - E27
  • [4] Anti-atherosclerotic mechanisms of statin therapy
    Babelova, Andrea
    Sedding, Daniel G.
    Brandes, Ralf P.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (02) : 260 - 264
  • [5] NATURAL PRODUCTS FOR ANTI-ATHEROSCLEROTIC THERAPY
    Kirichenko, T.
    Orekhova, V.
    Myasoedova, V.
    Melnichenko, A.
    Sobenin, I.
    Orekhov, A.
    [J]. ATHEROSCLEROSIS, 2019, 287 : E152 - E152
  • [6] Direct Anti-Atherosclerotic Therapy; Development of Natural Anti-Atherosclerotic Drugs Preventing Cellular Cholesterol Retention
    Orekhov, Alexander N.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (33) : 5909 - 5928
  • [7] Mechanisms of Atherogenesis and Development of Anti-Atherosclerotic Therapy
    Orekhov, Alexander N.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (09) : 1103 - 1106
  • [8] Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
    Sobenin, Igor A.
    Chistiakov, Dimitry A.
    Bobryshev, Yuri V.
    Orekhov, Alexander N.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (33) : 5954 - 5962
  • [9] Novel Anti-inflammatory Interleukin-35 as an Emerging Target for Anti-atherosclerotic Therapy
    Bobryshev, Yuri V.
    Sobenin, Igor A.
    Orekhov, Alexander N.
    Chistiakov, Dimitry A.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (09) : 1147 - 1151
  • [10] Potential Use of Dendritic Cells for Anti-Atherosclerotic Therapy
    Van Brussel, Ilse
    Schrijvers, Dorien M.
    Van Vre, Emily A.
    Bult, Hidde
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (33) : 5873 - 5882
12345